| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/26/2011 | CA2781248A1 Monoclonal antibodies and diagnostic uses thereof |
| 05/26/2011 | CA2781159A1 Human artificial chromosome vector |
| 05/26/2011 | CA2781099A1 Improved bacterial membrane protein secrection |
| 05/26/2011 | CA2781032A1 Ifny inhibitors in the treatment of motoneuron diseases |
| 05/26/2011 | CA2781019A1 Display of disulfide linked dimeric proteins on filamentous phage |
| 05/26/2011 | CA2780945A1 Human artificial chromosome vector |
| 05/26/2011 | CA2780807A1 Methods, devices, kits and compositions for detecting roundworm |
| 05/26/2011 | CA2780242A1 Multivalent antibodies |
| 05/26/2011 | CA2778864A1 Humanized antibodies against human il-22ra |
| 05/25/2011 | EP2325339A2 Methods and compositions for generation of germline human antibody genes |
| 05/25/2011 | EP2325317A1 Receptor nucleic acids and polypeptides |
| 05/25/2011 | EP2325316A1 Novel hemopoietin receptor protein, nr10 |
| 05/25/2011 | EP2325310A1 Method for obtaining purkinje progenitor cell by using neph3(65b13) and e-cadherin |
| 05/25/2011 | EP2325210A1 Monoclonal antibodies against Claudin-18 for treatment of cancer |
| 05/25/2011 | EP2325209A2 Improved protofibril selective antibodies and the use thereof |
| 05/25/2011 | EP2325208A1 Polyubiquitin antibodies |
| 05/25/2011 | EP2325207A2 FC variants with altered binding to FCRN |
| 05/25/2011 | EP2325206A2 FC variants with altered binding to FCRN |
| 05/25/2011 | EP2325205A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 05/25/2011 | EP2325204A2 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 05/25/2011 | EP2325203A2 Cadherin materials and methods |
| 05/25/2011 | EP2325196A1 Replikin peptides and uses thereof |
| 05/25/2011 | EP2324855A1 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 05/25/2011 | EP2324851A1 Methods of administering anti-TNFalpha antibodies |
| 05/25/2011 | EP2324844A2 April receptor (BCMA) and uses thereof |
| 05/25/2011 | EP2324843A1 Use of TNF-alpha inhibitors for treating nerve root injury |
| 05/25/2011 | EP2324839A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 05/25/2011 | EP2324359A1 Monoclonal antibody stro-4 |
| 05/25/2011 | EP2324347A1 Lcms technology and its uses |
| 05/25/2011 | EP2324061A1 Multispecific antibodies |
| 05/25/2011 | EP2324060A1 Anti-extended type i glycosphingolipid antibody, derivatives thereof and use |
| 05/25/2011 | EP2324059A1 Anti-pamp therapeutic antibodies |
| 05/25/2011 | EP1664118B1 Tlr2 antagonistic antibody and use thereof |
| 05/25/2011 | EP1629095B1 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 05/25/2011 | EP1374902B1 Anti-AILIM antibodies for the treatment of Crohn's disease |
| 05/25/2011 | EP1366077B1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
| 05/25/2011 | EP1263463B1 Use of an antibody or an immunotoxin that selectively binds to cd123 to impair hematologic cancer progenitor cells |
| 05/25/2011 | EP1183330B1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN |
| 05/25/2011 | EP0959896B1 Method of producing secreted truncated variants of human thyrotropin receptor |
| 05/25/2011 | CN1772897B Cell factor with several functions |
| 05/25/2011 | CN102076842A Induction of flocculation in photosynthetic organisms |
| 05/25/2011 | CN102076716A Stable and soluble antibodies inhibiting tnfa |
| 05/25/2011 | CN102076715A Solubility optimization of immunobinders |
| 05/25/2011 | CN102076714A Humanized antibodies which bind to a beta (1-42) globulomer and uses thereof |
| 05/25/2011 | CN102076713A Improved fibronectin-based binding molecules and uses thereof |
| 05/25/2011 | CN102071205A Specific antigen of clonorchis sinensis and application thereof |
| 05/25/2011 | CN102071170A Monoclonal antibody capable of resisting heavy metal copper and preparation method thereof |
| 05/25/2011 | CN102071169A Hybridoma of DON (Deoxynivalenol) monoclonal antibody as well as preparation method and application thereof |
| 05/25/2011 | CN102070718A Polyclonal antibodies of human tau protein exons 2, 3 and 10 |
| 05/25/2011 | CN102070716A Interleukin-10 antibody |
| 05/25/2011 | CN102070715A Human antibodies that bind human TNF alpha |
| 05/25/2011 | CN102070710A Specific GRA2a (Glycine Rich Antigen)-type antigenic protein of clonorchis sinensis and application thereof |
| 05/25/2011 | CN101597267B Melamine hapten, antigen and preparation method and applications thereof |
| 05/25/2011 | CN101361972B Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component |
| 05/25/2011 | CN101120015B Interleukin-15 antagonist peptide |
| 05/25/2011 | CN101074265B Recombinant anti-TNFR monoclonal antibody, its production and use |
| 05/25/2011 | CN101074262B Recombinant anti-FL moncclonal antibody, its production and use |
| 05/24/2011 | US7947812 Neoplasm specific antibodies and uses thereof |
| 05/24/2011 | US7947811 Antibodies that bind specifically to human RON protein |
| 05/24/2011 | US7947810 Kits for diagnosing a hypophosphatemic disorder |
| 05/24/2011 | US7947808 Toxin detection method |
| 05/24/2011 | US7947645 APO E analogs and methods for their use |
| 05/24/2011 | US7947496 Screening for cytotoxic end-points; cancerous disease modifying antibodies |
| 05/24/2011 | US7947472 An expression vector comprising a sequence of human DNA encoding vascular endothelial growth factor-D (VEGF-D) or a fragment having the biological activity of VEGF-D, inserted into a mammalian expression vector |
| 05/24/2011 | US7947463 Diagnosing cancer; measure antibody inhibitor, compare to control, reduced amounts of inhibitor indicates receptivity to cancer |
| 05/24/2011 | US7947462 Methods for identifying Kremen polypeptide binding partners |
| 05/24/2011 | US7947459 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 05/24/2011 | US7947452 Oligonucleotides originating from sequences coding for the surface component of PTLV envelope proteins and their uses |
| 05/24/2011 | US7947449 Methods of diagnosing pre-eclampsia or eclampsia |
| 05/24/2011 | US7947289 Multimeric protein toxins to target cells having multiple identifying characteristics |
| 05/24/2011 | US7947282 Methods of treatment using vascular occlusion in combination therapies |
| 05/24/2011 | US7947276 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| 05/24/2011 | US7947275 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 05/24/2011 | US7947274 Human cytomegalovirus neutralising antibodies and use thereof |
| 05/24/2011 | US7947273 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma |
| 05/24/2011 | US7947272 Using mixture comprising inhibitors of CD4, CD25 and interleukin induction as tool in reducing immune response to tissue graft; preventing transplant rejection |
| 05/24/2011 | US7947271 Methods of decreasing tumor volume and reducing tumor burden using TNF-receptor-coupling agents |
| 05/24/2011 | US7947254 Method of detecting a neuromyelitis optica specific-autoantibody by an antigenic aquaporin-4 polypeptide |
| 05/24/2011 | CA2541651C Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 05/24/2011 | CA2453001C Method of testing a mammal for its predisposition for fat content of milk and/or its predisposition for meat marbling |
| 05/24/2011 | CA2401604C Method of treating cancer with anti-neurotrophin agents |
| 05/24/2011 | CA2385266C Novel cell cycle checkpoint genes and proteins encoded thereby |
| 05/24/2011 | CA2375115C Method for separating cells using immunorosettes |
| 05/24/2011 | CA2360382C Use of antibodies for the vaccination against cancer |
| 05/24/2011 | CA2341642C Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 05/24/2011 | CA2337754C Recombinant multivalent malarial vaccine against plasmodium falciparum |
| 05/24/2011 | CA2323072C Gfr.alpha.3 and its uses |
| 05/24/2011 | CA2319310C Equine fc epsilon receptor alpha chain nucleic acid molecules, corresponding proteins and uses thereof |
| 05/24/2011 | CA2270913C Human tumor necrosis factor receptor-like 2 |
| 05/24/2011 | CA2266640C Methods for treating an ischemic disorder and improving stroke outcome |
| 05/24/2011 | CA2247067C Meltrins |
| 05/24/2011 | CA2211687C Vascular endothelial growth factor-b |
| 05/24/2011 | CA1341615C Targeted multifunctional proteins |
| 05/24/2011 | CA1341614C Targeted multifuncional proteins |
| 05/19/2011 | WO2011060233A1 Anti-tem1 antibodies and uses thereof |
| 05/19/2011 | WO2011060206A2 Material and methods for treating or preventing her-3 associated diseases |
| 05/19/2011 | WO2011060182A1 Monoclonal antibodies against gmf-beta antigens, and uses therefor |
| 05/19/2011 | WO2011060076A1 Anti-c-mpl antibodies |
| 05/19/2011 | WO2011059762A1 Anti-egfr antibodies and their uses |
| 05/19/2011 | WO2011058517A1 Single-chain variable fragment (scfv) able to recognize and bind cd99 human protein |